To hear about similar clinical trials, please enter your email below
Trial Title:
Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators
NCT ID:
NCT05932719
Condition:
Hepatocellular Carcinoma
Peritoneal Carcinoma
Conditions: Official terms:
COVID-19
Carcinoma
Carcinoma, Hepatocellular
Conditions: Keywords:
COVID-19
Cancer
Health Care Quality Indicators
hepatocellular carcinoma
peritoneal carcinosis
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Other
Intervention name:
COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
Description:
The following items will be collected
- Diagnostic date
- Diagnostic stage
- Date of surgery
- Date of surgery appointment
- First antineoplastic treatment date
- Last antineoplastic treatment date
- Number of treatment cycles recommanded by MDTM
Arm group label:
Hepatocellular Carcinoma
Arm group label:
Peritoneal Carcinosis
Summary:
The COVID-19 pandemic has deeply and globally impacted usual procedures and patients
management in cancer centers. The aim of this study is to set-up and collect indicators
to follow-up the activities of different cancer pathologies before and during the
pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to
care (surgery, antineoplastic treatments).
Data collection will focus on the analysis of 2 specific pathologies for French patients
in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.
Criteria for eligibility:
Study pop:
Patients hospitalized in France for peritoneal carcinosis or hepatocellular carcinoma
between 2017 and 2020.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patients hospitalized in France for peritoneal carcinosis or hepatocellular
carcinoma between 2017 and 2020.
Exclusion Criteria:
- Patients who did not allow the reuse of their medical data for research
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Hopital Lyon sud, Hospices civils de Lyon
Address:
City:
Pierre-Bénite
Zip:
69495
Country:
France
Status:
Recruiting
Contact:
Last name:
Julien PERON, MD
Phone:
4 78 86 37 75
Phone ext:
+33
Email:
julien.peron@chu-lyon.fr
Start date:
December 1, 2022
Completion date:
December 1, 2024
Lead sponsor:
Agency:
Hospices Civils de Lyon
Agency class:
Other
Source:
Hospices Civils de Lyon
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05932719
